---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-000521"
form_type: "8-K"
ticker: "EXPO"
cik: "0000851520"
company_name: "EXPONENT INC"
filed_at: "2024-02-01T23:59:59+00:00"
generated_at: "2026-06-06T12:21:10.181498+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Exponent Q4 net income down to $0.41 EPS; raises dividend to $0.28, adds $61.6M buyback

## Summary
- Q4 revenues before reimbursements $113.9M (+1.1% YoY); net income $20.9M ($0.41 diluted EPS) vs $22.5M ($0.44) prior year.
- FY2023 net revenues $497.2M (+7.2%); net income $100.3M ($1.94 diluted EPS) vs $102.3M ($1.96).
- Guidance: FY2024 revenues before reimbursements flat to down low-single digits; EBITDA margin 25.75%-26.5%.
- Quarterly dividend raised to $0.28 from $0.26, payable March 22, 2024; record March 8, 2024.
- Board authorized additional $61.6M for share repurchases, total authorization $100M.

## SEC filing metadata
- accession: 0001171843-24-000521
- form_type: 8-K
- ticker: EXPO
- cik: 0000851520
- company_name: EXPONENT INC
- filed_at: 2024-02-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/f8k_020124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-000521
- JSON: https://secwatch.observer/filing/0001171843-24-000521.json
- Plain text: https://secwatch.observer/filing/0001171843-24-000521.txt

## Key facts
- Earnings Releases
  EXPONENT INC reported fiscal year 2023 ended December 29, 2023 results: revenue $536.8 million, net income $100.3 million, EPS $1.94 per diluted share.
  - Period: fiscal year 2023 ended December 29, 2023
  - Revenue: $536.8 million
  - Net income: $100.3 million
  - EPS: $1.94 per diluted share
  - Result: reported results
  source text: Total revenues increased 4.6% to $536.8 million for fiscal year 2023, as compared to $513.3 million in fiscal year 2022. Revenues before reimbursements increased 7.2% to $497.2 million, as compared to $463.8 million in fiscal year 2022. Net income was $100.3 million, or $1.94 per diluted share, during fiscal year 2023, as compared to $102.3 million, or $1.96 per diluted share, in fiscal year 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm
- Earnings Releases
  EXPONENT INC updated its fiscal year 2024 guidance (lowered).
  - Period: fiscal year 2024
  - Guidance: lowered
  - Result: guidance update
  source text: For fiscal year 2024 as compared to fiscal year 2023, Exponent anticipates: Revenues before reimbursements to be flat to down in the low-single digits; and, EBITDA 1 to be 25.75% to 26.5% of revenues before reimbursements.
  evidence_url: https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm
- Earnings Releases
  EXPONENT INC reported fourth quarter ended December 29, 2023 results: revenue $122.9 million, net income $20.9 million, EPS $0.41 per diluted share.
  - Period: fourth quarter ended December 29, 2023
  - Revenue: $122.9 million
  - Net income: $20.9 million
  - EPS: $0.41 per diluted share
  - Result: reported results
  source text: Total revenues decreased 3.5% to $122.9 million in the fourth quarter of 2023, as compared to $127.4 million in the fourth quarter of 2022. Revenues before reimbursements increased 1.1% to $113.9 million, as compared to $112.6 million in the fourth quarter of 2022. Net income decreased to $20.9 million, or $0.41 per diluted share, in the fourth quarter of 2023, as compared to $22.5 million, or $0.44 per diluted share, in the same period of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/851520/000117184324000521/0001171843-24-000521-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.